Nicole Williams

1.6k total citations
64 papers, 677 citations indexed

About

Nicole Williams is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Nicole Williams has authored 64 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 25 papers in Pulmonary and Respiratory Medicine and 20 papers in Cancer Research. Recurrent topics in Nicole Williams's work include Breast Cancer Treatment Studies (17 papers), HER2/EGFR in Cancer Research (13 papers) and Cancer survivorship and care (13 papers). Nicole Williams is often cited by papers focused on Breast Cancer Treatment Studies (17 papers), HER2/EGFR in Cancer Research (13 papers) and Cancer survivorship and care (13 papers). Nicole Williams collaborates with scholars based in United States, United Kingdom and Spain. Nicole Williams's co-authors include Maryam B. Lustberg, Dionisia Quiroga, Jasmine Sukumar, Anne M. Noonan, Robert Wesolowski, Bhuvaneswari Ramaswamy, Raquel E. Reinbolt, Daniel G. Stover, Jeffrey VanDeusen and Janine Overcash and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Nicole Williams

56 papers receiving 670 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicole Williams United States 15 349 165 143 139 60 64 677
Travis Dockter United States 14 560 1.6× 160 1.0× 103 0.7× 80 0.6× 83 1.4× 43 860
Nicla La Verde Italy 16 514 1.5× 127 0.8× 171 1.2× 212 1.5× 36 0.6× 64 868
Tarık Salman Türkiye 16 314 0.9× 107 0.6× 61 0.4× 84 0.6× 19 0.3× 67 585
Haitao Xu China 14 88 0.3× 84 0.5× 164 1.1× 216 1.6× 27 0.5× 53 717
A.K.L. Reyners Netherlands 17 408 1.2× 233 1.4× 101 0.7× 234 1.7× 46 0.8× 55 954
Maximilian Marhold Austria 14 361 1.0× 201 1.2× 156 1.1× 289 2.1× 29 0.5× 48 713
Benjamin Esparaz United States 10 327 0.9× 189 1.1× 83 0.6× 169 1.2× 22 0.4× 33 620
Maria Alice Franzoi France 16 568 1.6× 332 2.0× 167 1.2× 155 1.1× 86 1.4× 51 868
Joris Diels Belgium 19 218 0.6× 224 1.4× 71 0.5× 186 1.3× 48 0.8× 113 1.1k
Anna Dodd Canada 11 568 1.6× 413 2.5× 254 1.8× 133 1.0× 59 1.0× 46 925

Countries citing papers authored by Nicole Williams

Since Specialization
Citations

This map shows the geographic impact of Nicole Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicole Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicole Williams more than expected).

Fields of papers citing papers by Nicole Williams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicole Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicole Williams. The network helps show where Nicole Williams may publish in the future.

Co-authorship network of co-authors of Nicole Williams

This figure shows the co-authorship network connecting the top 25 collaborators of Nicole Williams. A scholar is included among the top collaborators of Nicole Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicole Williams. Nicole Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meisel, Jane, Katia Khoury, A. Jo Chien, et al.. (2024). Rates of pathologic complete response (pCR)after neoadjuvant datopotamab deruxtecan (Dato): Results from the I-SPY2.2 trial.. Journal of Clinical Oncology. 42(17_suppl). LBA509–LBA509. 4 indexed citations
2.
Loman, Brett R., Sagar Sardesai, Nicole Williams, et al.. (2024). Baseline gut microbiome alpha diversity predicts chemotherapy-induced gastrointestinal symptoms in patients with breast cancer. npj Breast Cancer. 10(1). 99–99. 2 indexed citations
3.
Sukumar, Jasmine, Sagar Sardesai, Ai Ni, et al.. (2024). Real‐world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancer. Cancer Medicine. 13(12). e7317–e7317.
4.
Sukumar, Jasmine, Sagar Sardesai, Ai Ni, et al.. (2023). Abstract P1-02-03: Real World Treatment Patterns of Adjuvant Endocrine Therapy and Ovarian Suppression in Premenopausal HR+/HER2+ Breast Cancer. Cancer Research. 83(5_Supplement). P1–2. 1 indexed citations
5.
6.
Madison, Annelise A., Megan E. Renna, Rebecca Andridge, et al.. (2023). Conflicts hurt: social stress predicts elevated pain and sadness after mild inflammatory increases. Pain. 164(9). 1985–1994. 5 indexed citations
7.
8.
Renna, Megan E., Annelise A. Madison, Juan Peng, et al.. (2023). Worry and Mindfulness Differentially Impact Symptom Burden Following Treatment Among Breast Cancer Survivors: Findings From a Randomized Crossover Trial. PubMed Central. 1 indexed citations
9.
Madison, Annelise A., Rebecca Andridge, Megan E. Renna, et al.. (2023). Inflamed but not impulsive: Acute inflammatory cytokine response does not impact prepotent response inhibition. Journal of Affective Disorders. 342. 1–9. 3 indexed citations
10.
Grimm, Michael, et al.. (2022). Updates in the Treatment of Chemotherapy-Induced Peripheral Neuropathy. Current Treatment Options in Oncology. 23(1). 29–42. 43 indexed citations
11.
12.
Strassels, Scott A., Karen O. Moss, Peter J. Mallow, et al.. (2021). Hospital Admissions Associated With Cancer Pain in Older Adults With and Without Dementia. Pain Management Nursing. 22(4). 496–502. 1 indexed citations
13.
Weber, Zachary, Katharine A. Collier, Juliet Forman, et al.. (2021). Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancer. Genome Medicine. 13(1). 89–89. 13 indexed citations
14.
Madison, Annelise A., Alex Woody, Maryam B. Lustberg, et al.. (2020). Cognitive problems of breast cancer survivors on proton pump inhibitors. Journal of Cancer Survivorship. 14(2). 226–234. 3 indexed citations
15.
Stover, Daniel G., Robert Wesolowski, Sagar Sardesai, et al.. (2020). Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study. World Journal of Surgical Oncology. 18(1). 11–11. 18 indexed citations
16.
Berger, Michael, Craig Vargo, Junan Li, et al.. (2019). Pathological complete response rates with pertuzumab-based neoadjuvant chemotherapy in breast cancer: A single-center experience. Journal of Oncology Pharmacy Practice. 26(3). 572–579. 4 indexed citations
17.
Padin, Avelina C., Stephanie J. Wilson, William B. Malarkey, et al.. (2019). Physical Activity After Breast Cancer Surgery: Does Depression Make Exercise Feel More Effortful than It Actually Is?. International Journal of Behavioral Medicine. 26(3). 237–246. 14 indexed citations
18.
Harbhajanka, Aparna, Kristy Miskimen, Paula Silverman, et al.. (2018). Clinicopathological, immunohistochemical and molecular correlation of neural crest transcription factor SOX10 expression in triple-negative breast carcinoma. Human Pathology. 80. 163–169. 27 indexed citations
19.
Varadan, Vinay, Sitharthan Kamalakaran, Hannah Gilmore, et al.. (2015). Brief‐exposure to preoperative bevacizumab reveals a TGF‐β signature predictive of response in HER2‐negative breast cancers. International Journal of Cancer. 138(3). 747–757. 14 indexed citations
20.
Taylor, K, Conor Kelly, John Bashford, et al.. (1996). Safety and logistical use of filgrastim (FG) mobilised granulocytes (FMG) in early management of severe neutropenic sepsis (SNS) in acute leukemia (AL) autograft. Blood. 88(10). 1384–1384. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Travis Dockter Breakdown of academic impact, for papers by Nicla La Verde Breakdown of academic impact, for papers by Tarık Salman Breakdown of academic impact, for papers by Haitao Xu Breakdown of academic impact, for papers by A.K.L. Reyners Breakdown of academic impact, for papers by Maximilian Marhold Breakdown of academic impact, for papers by Benjamin Esparaz Breakdown of academic impact, for papers by Maria Alice Franzoi Breakdown of academic impact, for papers by Joris Diels Breakdown of academic impact, for papers by Anna Dodd
Rankless by CCL
2026